Division NotesF1
United Kingdom
I.
- 1Division 1
- 2Division 2
- 3Division 3
- 4Division 4
- 5Division 5
- 6Division 6
- 7Division 7
- 8Division 8
- 9Division 9
- 10Division 10
- 11Division 11
- 12Division 12
- 13Division 13
- 14Box 19:
Annotations
Textual amendments
- F1
Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.
Notes on Annex III
Textual amendments
- F2
Annex 3 Form heading: words “UNITED KINGDOM ” substituted for “EUROPEAN UNION” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)
- F3
Annex 3 Form box 22: word “UK” substituted for “EU” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(a)(ii)(aa); 2020 c. 1, Sch. 5 para. 1(1)
- F4
Annex 3 Form box 22: words “United Kingdom” substituted for “customs territory of the Union” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(a)(ii)(bb); 2020 c. 1, Sch. 5 para. 1(1)
- F5
Annex 3 Form heading: words “European Union or Great Britain” substituted for “United Kingdom” (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(7)(a)(i)
- F6
Annex 3 Form box 22: words “Great Britain/the EU” substituted for “the UK” (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(7)(a)(ii)(aa)
- F7
Annex 3 Form box 22: words “Great Britain/the customs territory of the Union” substituted for “the United Kingdom” (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(7)(a)(ii)(bb)